RNA-seq and ChIP-seq in MCF7 cells treated with H3B-6545, H3B-9709, Fulvestrant and Tamoxifen

NIAID Data Ecosystem2026-03-13 收录

乳腺癌内分泌治疗

药物转录组与表观组

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178373 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

创建时间：

2022-06-14

Sample Demographics.

癌症患者特征

乳腺癌内分泌治疗

Values are Mean (Standard Deviation), (Range). 1 M = one month post chemotherapy completion (or yoked intervals). aP value for one-way ANOVA with treatment groups for age, education, IQ, handedness,

NIAID Data Ecosystem100

SET ER/PR - A robust 18-gene Predictor for Sensitivity to Endocrine Therapy for Metastatic Breast Cancer. SET ER/PR - A robust 18-gene Predictor for Sensitivity to Endocrine Therapy for Metastatic Breast Cancer

乳腺癌内分泌治疗

肿瘤生物标志物

There is clinical need to predict sensitivity of metastatic hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer to endocrine therapy, and targeted RNA sequencing (RNAseq) offers diag

NIAID Data Ecosystem90

Tamoxifen_Based_乳腺癌女性生殖系统超声队列研究数据

乳腺癌内分泌治疗

妇科超声监测

本数据集为基于超声的队列研究数据，研究他莫昔芬对乳腺癌女性生殖系统的影响。研究在巴格达三家肿瘤中心开展，纳入255例雌激素受体阳性乳腺癌患者（140例绝经前、115例绝经后），患者术后接受他莫昔芬辅助治疗至少3个月。数据记录患者年龄、绝经状态、合并症及用药情况，共包含1个文件。

海数据40

Low and High Dose Progestins Elicit Distinct Breast Cancer Biology. Homo sapiens

乳腺癌内分泌治疗

激素剂量效应

An incomplete understanding of dose-dependent progesterone receptor (PR) biology has led to the suboptimal exploitation of PR as a therapeutic target. While hormone replacement therapies (HRT) contain

NIAID Data Ecosystem90

A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy - Table 4

乳腺癌内分泌治疗

依从性研究

Obtaining and understanding information regarding endocrine therapy among persisters and non-persisters: A range of exemplars.

NIAID Data Ecosystem70